![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
113 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Evidence-Based GI: An ACG Publication and Podcast American College of Gastroenterology
-
- Health & Fitness
-
-
4.4 • 7 Ratings
-
A new monthly publication from the American College of Gastroenterology, Evidence-Based GI (EBGI) uses evidence-based methods to create abstracts and explain study results of new and important articles in the field of gastroenterology and hepatology. Listen as editors of EBGI discuss the articles they review and how the recommendations can be applied to your practice.
-
Do Not Extend Interval Between CRC Screening Colonoscopies from 10 to 15 Years: Perils of Administrative Databases
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Longer interval between first colonoscopy with negative findings for colorectal cancer and repeat colonoscopy,” by Liang Q, Mukama T, Sundquist K, et al. JAMA Oncology 2024; In Press.
-
Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Efficacy and safety of ustekinumab for ulcerative colitis through 4 years: final results of the UNIFI long-term maintenance study,” by Afif W, Arasaradnam RP, Abreu MT, Danese S, et al. Am J Gastroenterol 2024 May 1;119(5):910-921.
-
Oral Vonoprazan for Prevention of High-Risk Peptic Ulcer Rebleeding: A Better Alternative than IV PPIs?
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Comparison of vonoprazan vs intravenous proton pump inhibitor for prevention of high-risk peptic ulcers rebleeding after successful endoscopic hemostasis: a multicenter randomized noninferiority trial,” by Geeratragool T, Kaosombatwattana U, Boonchote A, et al. Gastroenterology 2024; In Press.
-
Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial
Philip Schoenfeld, MD, MSEd, MSc (Epi) discusses “Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis,” by Loomba R, Hartman ML, Lawitz EJ, et al. N Engl J Med June 8, 2024.
-
Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding?
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jeffrey Lee, MD, MPH discuss “The efficacy of metoclopramide for gastric visualization by endoscopy in patients with active upper gastrointestinal bleeding: double-blind randomized controlled trial,” by Vimonsuntirungsri T, Thungsuk R, Nopjaroonsri P, et al. Am J Gastroenterol 2024 May 1;119(5):846-855. PMID: 38059896.
-
Multi-Target Stool RNA Test for Colorectal Cancer Screening: When Should You Use It?
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Multitarget stool RNA for colorectal cancer screening,” by Barnell EK, Wurtzler EM, La Rocca J, et al. JAMA 2023; 330: 1760-68.